These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-004561-34 Tranexamic acid to elderly patients undergoing combined AVR and CABG surgery. not-yet-due
No trial status on register 2006-006469-17 A multicenter study to investigate the Sensitivity and Specificity of Aridol (Mannitol)Challenge as compared with Methacholine Challenge to predict a diagnosis of Asthma by a Specialist Pulmonologist ... bad-data
Reported results 2010-022897-14 A feasibility study of Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia - the pre-MENAC study. 2014-09-01 due-trials
Other 2012-001338-32 Dopamine agonist treatment of non-functioning pituitary adenomas (NFPAs) - a randomized controlled trial. The efficacy of cabergoline on tumour volume in previously untreated macroadenomas or residual... not-yet-due
Ongoing 2012-001578-26 An international, multicentre, open randomised parallel group trial comparing a two step approach to cancer pain relief with the standard three step approach of the WHO analgesic ladder in patients wi... not-yet-due
Ongoing 2012-004381-18 Treatment of morbid obesity through intra-gastric injections of Botulinum toxin A: A pilot study not-yet-due
Listed as ongoing, but also has a completion date 2014-002539-32 Does botulinum toxin A make walking easier i in children with cerebral palsy? 2021-12-31 bad-data
Other 2014-004075-23 A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cancer not-yet-due
Completed, but no date, and reported results 2015-000295-94 Use of long acting opioids for pre- and postoperative analgesia in primary total knee arthroplasty. A double-blinded randomized control trial. Tapentadol vs Oxycodon vs Placebo bad-data
Ongoing 2015-001077-40 INNOVATIVE STEROID TREATMENT TO REDUCE ASTHMA DEVELOPMENT IN CHILDREN AFTER FIRST-TIME RHINOVIRUS INDUCED WHEEZING – THE INSTAR STUDY not-yet-due
Ongoing 2015-001635-21 Nordic Pancreatic Cancer Trial not-yet-due
Reported results 2015-004463-37 ACUTE AND LONG-TERM EFFECTS OF INTRANASAL OXYTOCIN IN ALCOHOL WITHDRAWAL AND DEPENDENCE: A PROSPECTIVE RANDOMIZED PARALLEL GROUP PLACEBO-CONTROLLED TRIAL 2017-11-30 due-trials
Reported results 2015-005306-11 Pharmacological treatment of insomnia in palliative care A randomized, double-blind, placebo controlled, parallel-group, multicenter trial investigating the short time effectiveness of zopiclone on ... 2021-05-31 due-trials
Ongoing 2016-000326-19 Treatment of obesity in adolescents by endoscopic injection of Botulinum toxin A - A randomised, double blind, placebo-controlled phase II-trial followed by an open-label cohort-controlled extension not-yet-due
Completed, but no date, and reported results 2017-002516-13 “Follow the sutures“. An open multicenter, multinational pilot study to explore tolerability, safety and effect of a new procedure for injecting botulinum toxin in the head against chronic migraine. bad-data
Other 2018-001044-54 A STUDY OF EFFICACY AND SAFETY OF LONG-ACTING LOW DOSE ROPEGINTERFERON IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH BOSUTINIB FROM DIAGNOSIS: A RANDOMIZED PROSPECTIVE TRIAL not-yet-due
Ongoing, reported early 2019-001179-35 Optimizing preoperative disinfection before ocular surgery Optimalisering av pre-operativ desinfeksjon ved okulær kirurgi (Norwegian) not-yet-due
Not reported 2019-001736-57 ULTRASOUND-ENHANCED UPTAKE OF CHEMOTHERAPY IN PATIENTS WITH INOPERABLE PANCREATIC DUCTAL ADENOCARCINOMA 2022-12-31 due-trials
Other 2019-002280-10 Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial not-yet-due
Completed, report not yet due 2019-003386-18 CandMig III study Candesartan for migraine prevention: A multicentre, binational, triple blind, placebo controlled, parallel group study of two doses of candesartan (8 and 16 mg) 2024-04-12 not-yet-due
Completed, but no date Terminated 2022-000800-37 An open, controlled investigation of the effect of micro-doses of glucagon on the performance of continuous glucose monitoring in patients with diabetes mellitus type 1. bad-data